Sarepta Therapeutics (SRPT) Shareholder's Equity Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.30% |
| Dec 31, 2025 | 43.63% |
| Sep 30, 2025 | 45.24% |
| Jun 30, 2025 | 23.17% |
| Mar 31, 2025 | 10.07% |
| Dec 31, 2024 | 18.08% |
| Sep 30, 2024 | 37.52% |
| Jun 30, 2024 | 30.46% |
| Mar 31, 2024 | 21.53% |
| Dec 31, 2023 | 4.10% |
| Sep 30, 2023 | -5.02% |
| Jun 30, 2023 | -10.75% |
| Mar 31, 2023 | -14.61% |
| Dec 31, 2022 | -22.22% |
| Sep 30, 2022 | -24.35% |
| Jun 30, 2022 | -12.89% |
| Mar 31, 2022 | -14.03% |
| Dec 31, 2021 | -3.49% |
| Sep 30, 2021 | -9.80% |
| Jun 30, 2021 | -11.47% |
| Mar 31, 2021 | -11.66% |
| Dec 31, 2020 | -1.17% |
| Sep 30, 2020 | 8.56% |
| Jun 30, 2020 | 40.28% |
| Mar 31, 2020 | 38.69% |
| Dec 31, 2019 | 34.44% |
| Sep 30, 2019 | 34.54% |
| Jun 30, 2019 | 108.39% |
| Mar 31, 2019 | 113.30% |
| Dec 31, 2018 | 75.69% |
| Sep 30, 2018 | 73.16% |
| Jun 30, 2018 | 61.69% |
| Mar 31, 2018 | 56.99% |
| Dec 31, 2017 | 47.16% |
| Sep 30, 2017 | 34.55% |
| Jun 30, 2017 | 8.00% |
| Mar 31, 2017 | 23.30% |
| Dec 31, 2016 | 10.85% |
| Sep 30, 2016 | 18.27% |
| Jun 30, 2016 | 11.00% |
| Mar 31, 2016 | 16.77% |
| Dec 31, 2015 | 15.46% |
| Mar 31, 2015 | 142.82% |
| Dec 31, 2014 | 99.87% |
| Sep 30, 2014 | 108.11% |
| Jun 30, 2014 | 104.35% |
| Dec 31, 2013 | 347.73% |